Poor coverage of psoriasis biologics in a cross-sectional analysis of Medicaid formularies
J Am Acad Dermatol
.
2022 Oct;87(4):900-903.
doi: 10.1016/j.jaad.2021.12.017.
Epub 2021 Dec 16.
Authors
Julianne M Falotico
1
,
Shari R Lipner
2
Affiliations
1
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.
2
Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.
PMID:
34922918
DOI:
10.1016/j.jaad.2021.12.017
No abstract available
MeSH terms
Biological Products* / therapeutic use
Cross-Sectional Studies
Humans
Medicaid
Psoriasis* / drug therapy
Substances
Biological Products